Antimicrobial activity and antibiotic synergy of a biphosphinic ruthenium complex against clinically relevant bacteria

References

• Abbadi BL, Rodrigues-Junior VS, Dadda AS, Pissinate K, Villela AD, Campos MM, Lopes LGF, Bizarro CV, Machado P, Sousa EHS, et al. 2018. Is IQG-607 a potential metallodrug or metallopro-drug with a defined molecular target in Mycobacterium tuberculosis? Front Microbiol. 9:880–8802. doi:10.3389/fmicb.2018.00880
   PubMed Web of Science ®Google Scholar
• Abdallah M, Benoliel C, Drider D, Dhulster P, Chihib NE. 2014. Biofilm formation and persistence on abiotic surfaces in the context of food and medical environments. Arch Microbiol. 196:453–472. doi:10.1007/s00203-014-0983-1
   PubMed Web of Science ®Google Scholar
• Abdelhady W, Bayer AS, Seidl K, Nast CC, Kiedrowski MR, Horswill AR, Yeaman MR, Xiong YQ. 2013. Reduced vancomycin susceptibility in an in vitro catheter-related biofilm model correlates with poor therapeutic outcomes in experimental endocarditis due to methicillin-resistant Staphylococcus aureus . Antimicrob Agents Chemother. 57:1447–1454. doi:10.1128/AAC.02073-12
   PubMed Web of Science ®Google Scholar
• Abreu FD, Paulo TF, Gehlen MH, Ando RA, Lopes LGF, Gondim ACS, Vasconcelos MA, Teixeira EH, Sousa EHS, Carvalho I. 2017. Aryl-substituted ruthenium(II) complexes: a strategy for enhanced photocleavage and efficient DNA binding. Inorg Chem. 56:9084–9096. doi:10.1021/acs.inorgchem.7b01108
   PubMed Web of Science ®Google Scholar
• Aminov RI. 2010. A brief history of the antibiotic era: lessons learned and challenges for the future. Front Microbiol. 1:134.
   PubMed Web of Science ®Google Scholar
• Arciola CR, Campoccia D, Montanaro D. 2018. Implant infections: adhesion, biofilm formation and immune evasion. Nat Rev Microbiol. 16:397–409. doi:10.1038/s41579-018-0019-y
   PubMed Web of Science ®Google Scholar
• Beeton ML, Aldrich-Wright JR, Bolhuis A. 2014. The antimicrobial and antibiofilm activities of copper(II) complexes. J Inorg Biochem. 140:167–172. doi:10.1016/j.jinorgbio.2014.07.012
   PubMed Web of Science ®Google Scholar
• Bhattacharya S, Bir R, Majumdar T. 2015. Evaluation of multidrug resistant Staphylococcus aureus and their association with biofilm production in a Tertiary Care Hospital, Tripura, Northeast India. J Clin Diagn Res. 9:DC01–DC04.
   PubMed Web of Science ®Google Scholar
• Bolhuis A, Hand L, Marshall JE, Richards AD, Rodger A, Aldrich-Wright J. 2011. Antimicrobial activity of ruthenium-based intercalators. Eur J Pharm Sci. 42:313–317. doi:10.1016/j.ejps.2010.12.004
   PubMed Web of Science ®Google Scholar
• Bressan M, Rigo P. 1975. Five-coordinate complexes of ruthenium (II) with di(tertiary phosphines). Inorg Chem. 14:2286–2288. doi:10.1021/ic50151a060
   Web of Science ®Google Scholar
• [CLSI] Clinical and Laboratory Standards Institute. 2015. Method for dilution antibacterial susceptibility tests for bacteria that grow aerobically: approved standard – 10^th ed. CLSI Document M07-A10. Wayne (PA): CLSI.
   Google Scholar
• [CLSI] Clinical and Laboratory Standards Institute. 2017. Performance standards for antimicrobial susceptibility testing: approved standard - 27^th ed. CLSI Document M100-S27. Wayne (PA): CLSI.
   Google Scholar
• Costerton JW, Stewart PS, Greenberg EP. 1999. Bacterial biofilms: a common cause of persistent infections. Science. 284:1318–1132. doi:10.1126/science.284.5418.1318
   PubMed Web of Science ®Google Scholar
• Cox G, Wright GD. 2013. Intrinsic antibiotic resistance: mechanisms, origins, challenges and solutions. Int J Med Microbiol. 303:287–292. doi:10.1016/j.ijmm.2013.02.009
   PubMed Web of Science ®Google Scholar
• da Silveira Carvalho JM, de Morais Batista AH, Nogueira NAP, Holanda AKM, de Sousa JR, Zampieri D, Bezerra MJB, Stefânio Barreto F, de Moraes MO, Batista AA, et al. 2017. A biphosphinic ruthenium complex with potent anti-bacterial and anti-cancer activity. New J Chem. 41:13085–13095. doi:10.1039/C7NJ02943H
   Web of Science ®Google Scholar
• Demirezen N, Tarınç D, Polat D, Ceşme M, Gölcü A, Tümer M. 2012. Synthesis of trimethoprim metal complexes: spectral, electrochemical, thermal, DNA-binding and surface morphology studies. Spectrochim Acta A Mol Biomol Spectrosc. 94:243–255. doi:10.1016/j.saa.2012.03.055
   PubMed Web of Science ®Google Scholar
• Dinelli LR, Batista AA, Wohnrath K, Araujo MP, Queiroz SL, Bonfadini MR, Oliva G, Nascimento OR, Cyr PW, MacFarlane KS, et al. 1999. Synthesis and characterization of [RuCl3(P-P)(H2O)] complexes; P-P = achiral or chiral, chelating ditertiary phosphine ligands. Inorg Chem. 38:5341–5345. doi:10.1021/ic990130c
   Google Scholar
• Fux CA, Costerton JW, Stewart OS, Stoodley P. 2005. Survival strategies of infectious biofilms. Trends Microbiol. 13:34–40. doi:10.1016/j.tim.2004.11.010
   PubMed Web of Science ®Google Scholar
• Gordon RJ, Lowy FD. 2008. Pathogenesis of methicillin- resistant Staphylococcus aureus infection. Clin Infect Dis. 46:S350–S359. doi:10.1086/533591
   PubMed Web of Science ®Google Scholar
• Hengzhuang W, Wu H, Ciofu O, Song Z, Høiby N. 2011. Pharmacokinetics/pharmacodynamics of colistin and imipenem on mucoid and nonmucoid Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother. 55:4469–4474. doi:10.1128/AAC.00126-11
   PubMed Web of Science ®Google Scholar
• Hensley BJ, Monson J. 2015. Hospital-acquired infections. Surgery. 33:528–533.
   Google Scholar
• Jamal M, Ahmad W, Andleeb S, Jalil F, Imran M, Nawaz MA, Hussain T, Ali M, Rafiq M, Kamil MA. 2018. Bacterial biofilm and associated infections. J Chin Med Assoc. 81:7–11. doi:10.1016/j.jcma.2017.07.012
   PubMed Web of Science ®Google Scholar
• Jenkins DR. 2017. Nosocomial infections and infection control. Medicine. 45:629–633. doi:10.1016/j.mpmed.2017.07.005
   Google Scholar
• Keynan Y, Rubinstein E. 2013. Staphylococcus aureus bacteremia, risk factors, complications, and management. Crit Care Clin. 29:547–562. doi:10.1016/j.ccc.2013.03.008
   PubMed Web of Science ®Google Scholar
• Khan HÁ, Baig FK, Mehboob R. 2017. Nosocomial infections: epidemiology, prevention, control and surveillance. Asian Pac J Trop Biomed. 7:478–482. doi:10.1016/j.apjtb.2017.01.019
   Web of Science ®Google Scholar
• Kim MJ, Kim CS, Park JY, Lim YK, Park SN, Ahn SJ, Jin DC, Kim TH, Kook JK. 2011. Antimicrobial effects of ursolic acid against Streptococcus mutans isolated from Koreans. Int J Oral Biol. 36:7–11.
   Google Scholar
• Kingston JV, Wilkinson G. 1966. Dithiocarbamato and rihalogenostannato carbonyl complexes of ruthenium (II). J Inorg Nucl Chem. 28:2709–2713. doi:10.1016/0022-1902(66)80397-4
   Web of Science ®Google Scholar
• Laxminarayan R, Duse A, Wattal C, Zaidi AKM, Wertheim HFL, Sumpradit N, Vlieghe E, Hara GL, Gould IM, Goossens H, et al. 2013. Antibiotic resistance-the need for global solutions. Lancet Infect Dis. 13:1057–1098. doi:10.1016/S1473-3099(13)70318-9
   PubMed Web of Science ®Google Scholar
• Li F, Collins JG, Keene FR. 2015. Ruthenium complexes as antimicrobial agents. Chem Soc Rev. 44:2529–2542. doi:10.1039/C4CS00343H
   PubMed Web of Science ®Google Scholar
• Li F, Feterl M, Mulyana Y, Warner JM, Collins JG, Keene FR. 2012. In vitro susceptibility and cellular uptake for a new class of antimicrobial agents: dinuclear ruthenium(II) complexes. J Antimicrob Chemother. 67:2686–2695. doi:10.1093/jac/dks291
   PubMed Web of Science ®Google Scholar
• Livornese LL, Korzeniowski OM. 1992. Pathogenesis of infective endocarditis. In: Kaye D, editor. Infective endocarditis. 2nd ed. New York (NY): Raven Press; p. 19–35.
   Google Scholar
• McCarthy H, Rudkin JK, Black NS, Gallagher L, O’Neill E, O’Gara JP. 2015. Methicillin resistance and the biofilm phenotype in Staphylococcus aureus. Front Cell Infect Microbiol. 5:1–9.
   PubMed Web of Science ®Google Scholar
• Moffa M, Guo W, Li T, Cronk R, Abebe LS, Bartram J. 2017. A systematic review of nosocomial waterborne infections in neonates and mothers. Int J Hyg Environ Health. 220:1199–1206. doi:10.1016/j.ijheh.2017.07.011
   PubMed Web of Science ®Google Scholar
• Malagoli D. 2007. A full-length protocol to test hemolytic activity of palytoxin on human erythrocytes. Invert Surviv J. 4:92–94.
   Web of Science ®Google Scholar
• Murray PR, Rosenthal KS, Pfaller MA. 2016. Medical microbiology. 8th ed. Philadelphia (PA): Elsevier/Saunders.
   Google Scholar
• Murray TS, Okegbe C, Gao Y, Kazmierczak BI, Motterlini R, Dietrich LEP, Bruscia EM. 2012. The carbon monoxide releasing molecule CORM-2 attenuates Pseudomonas aeruginosa biofilm formation. PLoS One. 7:e35499. doi:10.1371/journal.pone.0035499
   PubMed Web of Science ®Google Scholar
• Naicker PR, Karayem K, Hoek KG, Harvey J, Wasserman E. 2016. Biofilm formation in invasive Staphylococcus aureus isolates is associated with the clonal lineage. Microb Pathog. 90:41–49. doi:10.1016/j.micpath.2015.10.023
   PubMed Web of Science ®Google Scholar
• Odds FC. 2003. Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother. 52:1. doi:10.1093/jac/dkg301
   PubMed Web of Science ®Google Scholar
• Otto M. 2008. Staphylococcal biofilms. Curr Top Microbiol Immunol. 322:207–228.
   PubMed Web of Science ®Google Scholar
• Post JC, Stoodley P, Hall-Stoodley L, Ehrlich GD. 2004. The role of biofilms in otolaryngologic infections. Curr Opin Otolaryngol Head Neck Surg. 12:185–190. doi:10.1097/01.moo.0000124936.46948.6a
   PubMedGoogle Scholar
• Raafat D, Otto M, Reppschläger K, Iqbal J, Holtfreter S. 2019. Fighting Staphylococcus aureus biofilms with monoclonal antibodies. Trends Microbiol. 27:303–322. doi:10.1016/j.tim.2018.12.009
   PubMed Web of Science ®Google Scholar
• Ramage G, Rajendran R, Sherry L, Williams C. 2012. Fungal biofilm resistance. Int J Microbiol. 2012:1–14. doi:10.1155/2012/528521
   Google Scholar
• Rhoads DD, Wolcott RD, Percival SL. 2008. Biofilms in wounds: management strategies. J Wound Care. 17:502–508. doi:10.12968/jowc.2008.17.11.31479
   PubMedGoogle Scholar
• Rolston KV, Wang W, Nesher L, Smith JR, Rybak MJ, Prince RA. 2017. Time-kill determination of the bactericidal activity of telavancin and vancomycin against clinical methicillin-resistant Staphylococcus aureus isolates from cancer patients. Diagn Microbiol Infect Dis. 87:338–342. doi:10.1016/j.diagmicrobio.2016.12.010
   PubMed Web of Science ®Google Scholar
• Sharma A, Gupta S, Sarethy IP, Dang S, Gabrani R. 2012. Green tea extract: possible mechanism and antibacterial activity on skin pathogens. Food Chem. 135:672–675. doi:10.1016/j.foodchem.2012.04.143
   PubMed Web of Science ®Google Scholar
• Silva JJN, Guedes PMM, Zottis A, Balliano TL, Silva FON, Lopes LGF, Ellena J, Oliva G, Andricopulo AD, Franco DW, et al. 2010. Novel ruthenium complexes as potential drugs for Chagas’s disease: enzyme inhibition and in vitro/in vivo trypanocidal activity. Br J Pharmacol. 160:260–269. doi:10.1111/j.1476-5381.2009.00524.x
   PubMed Web of Science ®Google Scholar
• Sousa EHS, Ridnour LA, Gouveia FS, Silva CD, Wink DA, Lopes L, Sadler PJ. 2016. Thiol-activated HNO release from a ruthenium antiangiogenesis complex and HIF-1α inhibition for cancer therapy. ACS Chem Biol. 11:2057–2065. doi:10.1021/acschembio.6b00222
   PubMed Web of Science ®Google Scholar
• Sousa AP, Ellena J, Gondim ACS, Lopes LGF, Sousa EHS, Vasconcelos MA, Teixeira EH, Ford PC, Holanda A. 2018. Antimicrobial activity of cis -[Ru(bpy) 2 (L)(L’)]n+ complexes, where L = 4-(4-chlorobenzoyl)pyridine or 4-(benzoyl)pyridine and L’= Cl− or CO. Polyhedron. 144:88–94. doi:10.1016/j.poly.2018.01.002
   Web of Science ®Google Scholar
• Stepanovic S, Vukovic D, Dakic I, Savic B, Svabic-Vlahovic M. 2000. A modified microtiter-plate test for quantification of staphylococcal biofilm formation. J Microbiol Methods. 40:175–179. doi:10.1016/S0167-7012(00)00122-6
   PubMed Web of Science ®Google Scholar
• Sun D, Zhang W, Lv M, Yang E, Zhao Q, Wang W. 2015. Antibacterial activity of ruthenium(II) polypyridyl complex manipulated by membrane permeability and cell morphology. Bioorg Med Chem Lett. 25:2068–2073. doi:10.1016/j.bmcl.2015.03.090
   PubMed Web of Science ®Google Scholar
• Tong SYC, Davis JS, Eichenberger E, Holland TL, Fowler VG, Jr. 2015. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and man- agement. Clin Microbiol Rev. 28:603–661. doi:10.1128/CMR.00134-14
   PubMed Web of Science ®Google Scholar
• Ude Z, Romero-Canelón I, Twamley B, Fitzgerald Hughes D, Sadler PJ, Marmion CJ. 2016. A novel dual-functioning ruthenium(II)-arene complex of an anti-microbial ciprofloxacin derivative - anti-proliferative and anti-microbial activity. J Inorg Biochem. 160:210–217. doi:10.1016/j.jinorgbio.2016.02.018
   PubMed Web of Science ®Google Scholar
• Vasconcelos MA, Arruda FVS, de Alencar DB, Saker-Sampaio S, Albuquerque MRJR, Dos Santos HS, Bandeira PN, Pessoa ODL, Cavada BS, Henriques M, et al. 2014. Antibacterial and antioxidant activities of derriobtusone A isolated from Lonchocarpus obtusus. Biomed Res Int. 2014:248656–248659.
   PubMed Web of Science ®Google Scholar
• Vasconcelos MA, Arruda FVS, Santos HS, Rodrigues AS, Bandeira PN, Albuquerque MRJR, Cavada BS, Teixeira EH, Henriques M, Pereira MO. 2014. Effect of a casbane diterpene isolated from Croton nepetaefolius on theprevention and control of biofilms formed by bacteria and Candida species. Ind Crop Prod. 61:499–509. doi:10.1016/j.indcrop.2014.07.027
   Web of Science ®Google Scholar
• Viganor L, Galdino ACM, Nunes APF, Santos KRN, Branquinha MH, Devereux M, Kellett A, McCann M, Santos ALS. 2016. Anti-Pseudomonas aeruginosa activity of 1,10-phenanthroline-based drugs against both planktonic- and biofilm-growing cells. J Antimicrob Chemother. 71:128–134. doi:10.1093/jac/dkv292
   PubMed Web of Science ®Google Scholar
• [WHO] World Health Organization. 2017. Antimicrobial resistance. Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics.
   Google Scholar